BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17983825)

  • 1. Flawed Australian CD study does not end MAP controversy.
    Lipton JE; Barash DP
    Gastroenterology; 2007 Nov; 133(5):1742; author reply 1745-6. PubMed ID: 17983825
    [No Abstract]   [Full Text] [Related]  

  • 2. Importance of the Australian Crohn's disease antibiotic study.
    Chamberlin W
    Gastroenterology; 2007 Nov; 133(5):1744-5; author reply 1745-6. PubMed ID: 17983827
    [No Abstract]   [Full Text] [Related]  

  • 3. The Australian antibiotic trial in Crohn's disease: alternative conclusions from the same study.
    Kuenstner JT
    Gastroenterology; 2007 Nov; 133(5):1742-3; author reply 1745-6. PubMed ID: 17983824
    [No Abstract]   [Full Text] [Related]  

  • 4. Australian Crohn's antibiotic study opens new horizons.
    Gitlin L; Biesecker J
    Gastroenterology; 2007 Nov; 133(5):1743-4; author reply 1745-6. PubMed ID: 17983826
    [No Abstract]   [Full Text] [Related]  

  • 5. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease.
    Selby W; Pavli P; Crotty B; Florin T; Radford-Smith G; Gibson P; Mitchell B; Connell W; Read R; Merrett M; Ee H; Hetzel D;
    Gastroenterology; 2007 Jun; 132(7):2313-9. PubMed ID: 17570206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with drugs active against Mycobacterium avium subspecies paratuberculosis can heal Crohn's disease: more evidence for a neglected public health tragedy.
    Hermon-Taylor J
    Dig Liver Dis; 2002 Jan; 34(1):9-12. PubMed ID: 11926580
    [No Abstract]   [Full Text] [Related]  

  • 7. Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease.
    Shafran I; Kugler L; El-Zaatari FA; Naser SA; Sandoval J
    Dig Liver Dis; 2002 Jan; 34(1):22-8. PubMed ID: 11930899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protagonist. Mycobacterium avium subspecies paratuberculosis is a cause of Crohn's disease.
    Hermon-Taylor J
    Gut; 2001 Dec; 49(6):755-6. PubMed ID: 11709506
    [No Abstract]   [Full Text] [Related]  

  • 9. Antimycobacterial therapy in Crohn's disease: game over?
    Peyrin-Biroulet L; Neut C; Colombel JF
    Gastroenterology; 2007 Jun; 132(7):2594-8. PubMed ID: 17570230
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn's disease: pharmacological and clinical implications.
    Savarino E; Bertani L; Ceccarelli L; Bodini G; Zingone F; Buda A; Facchin S; Lorenzon G; Marchi S; Marabotto E; De Bortoli N; Savarino V; Costa F; Blandizzi C
    Expert Opin Biol Ther; 2019 Feb; 19(2):79-88. PubMed ID: 30574820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of Mycobacterium avium paratuberculosis in the etiopathogenesis of Crohn's disease].
    Ormaechea JI; Gisbert JP; Marín-Jiménez I
    Gastroenterol Hepatol; 2009 May; 32(5):353-63. PubMed ID: 19457586
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment of a Crohn's disease patient infected with bacteremic Mycobacterium paratuberculosis.
    Chamberlin W; Ghobrial G; Chehtane M; Naser SA
    Am J Gastroenterol; 2007 Mar; 102(3):689-91. PubMed ID: 17335456
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of interactions of antibacterial drugs with each other and with 6-mercaptopurine on in vitro growth of Mycobacterium avium subspecies paratuberculosis.
    Krishnan MY; Manning EJ; Collins MT
    J Antimicrob Chemother; 2009 Nov; 64(5):1018-23. PubMed ID: 19759042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of severe Crohn's disease using antimycobacterial triple therapy--approaching a cure?
    Borody TJ; Leis S; Warren EF; Surace R
    Dig Liver Dis; 2002 Jan; 34(1):29-38. PubMed ID: 11926571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium paratuberculosis cervical lymphadenitis, followed five years later by terminal ileitis similar to Crohn's disease.
    Hermon-Taylor J; Barnes N; Clarke C; Finlayson C
    BMJ; 1998 Feb; 316(7129):449-53. PubMed ID: 9492675
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of antimycobacterial agents in Crohn's disease.
    Thayer WR
    J Clin Gastroenterol; 1992 Jul; 15(1):5-7. PubMed ID: 1323594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The etiology of Mycobacterium avium subspecies paratuberculosis in Crohn's disease.
    Alluwaimi AM
    Saudi Med J; 2007 Oct; 28(10):1479-84. PubMed ID: 17914503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uveitis in a patient receiving rifabutin for Crohn's disease.
    Awotesu O; Missotten T; Pitcher MC; Lynn WA; Lightman S
    J R Soc Med; 2004 Sep; 97(9):440-1. PubMed ID: 15340029
    [No Abstract]   [Full Text] [Related]  

  • 19. Resolution of Crohn's (Johne's) disease with antibiotics: what are the next steps?
    Davis WC; Kuenstner JT; Singh SV
    Expert Rev Gastroenterol Hepatol; 2017 May; 11(5):393-396. PubMed ID: 28276276
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective Th2 pattern of cytokine secretion in Mycobacterium avium subsp. paratuberculosis infected Crohn's disease.
    Ren Z; Turton J; Borody T; Pang G; Clancy R
    J Gastroenterol Hepatol; 2008 Feb; 23(2):310-4. PubMed ID: 18289359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.